293 related articles for article (PubMed ID: 10461068)
1. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors.
Schmidt MH; Reichert KW; Ozker K; Meyer GA; Donohoe DL; Bajic DM; Whelan NT; Whelan HT
Pediatr Neurosurg; 1999 May; 30(5):225-31. PubMed ID: 10461068
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors.
Schmidt MH; Meyer GA; Reichert KW; Cheng J; Krouwer HG; Ozker K; Whelan HT
J Neurooncol; 2004; 67(1-2):201-7. PubMed ID: 15072468
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.
Karagianis G; Hill JS; Stylli SS; Kaye AH; Varadaxis NJ; Reiss JA; Phillips DR
Br J Cancer; 1996 Feb; 73(4):514-21. PubMed ID: 8595167
[TBL] [Abstract][Full Text] [Related]
4. The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model.
Whelan HT; Schmidt MH; Segura AD; McAuliffe TL; Bajic DM; Murray KJ; Moulder JE; Strother DR; Thomas JP; Meyer GA
J Neurosurg; 1993 Oct; 79(4):562-8. PubMed ID: 8410226
[TBL] [Abstract][Full Text] [Related]
5. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of brain tumors.
Popovic EA; Kaye AH; Hill JS
J Clin Laser Med Surg; 1996 Oct; 14(5):251-61. PubMed ID: 9612191
[TBL] [Abstract][Full Text] [Related]
7. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
[TBL] [Abstract][Full Text] [Related]
8. Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents.
Davis N; Liu D; Jain AK; Jiang SY; Jiang F; Richter A; Levy JG
Photochem Photobiol; 1993 Apr; 57(4):641-7. PubMed ID: 8506392
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors.
Osaki T; Takagi S; Hoshino Y; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 2009 Feb; 71(2):125-32. PubMed ID: 19262021
[TBL] [Abstract][Full Text] [Related]
11. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
Akimoto J; Haraoka J; Aizawa K
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):91-9. PubMed ID: 22594978
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors.
Muragaki Y; Akimoto J; Maruyama T; Iseki H; Ikuta S; Nitta M; Maebayashi K; Saito T; Okada Y; Kaneko S; Matsumura A; Kuroiwa T; Karasawa K; Nakazato Y; Kayama T
J Neurosurg; 2013 Oct; 119(4):845-52. PubMed ID: 23952800
[TBL] [Abstract][Full Text] [Related]
14. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
[TBL] [Abstract][Full Text] [Related]
15. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
Hill JS; Kahl SB; Stylli SS; Nakamura Y; Koo MS; Kaye AH
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12126-30. PubMed ID: 8618857
[TBL] [Abstract][Full Text] [Related]
16. New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors.
Eljamel MS
Technol Cancer Res Treat; 2003 Aug; 2(4):303-9. PubMed ID: 12892512
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of brain tumors--a work in progress.
Muller PJ; Wilson BC
Lasers Surg Med; 2006 Jun; 38(5):384-9. PubMed ID: 16788926
[TBL] [Abstract][Full Text] [Related]
18. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
19. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
Busetti A; Soncin M; Jori G; Rodgers MA
Br J Cancer; 1999 Feb; 79(5-6):821-4. PubMed ID: 10070875
[TBL] [Abstract][Full Text] [Related]
20. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
